ERIC SMITH: Open Payments
NPI 1295736742 · CLARKS SUMMIT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,301 in 236 payments from 32 companies in 2025. Trend: 2023 $3,682 · 2024 $3,329 · 2025 $4,301
Food & beverage: $4,221Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $623 |
| AstraZeneca Pharmaceuticals LP | 14 | $435 |
| Lilly USA, LLC | 23 | $327 |
| Lundbeck LLC | 17 | $294 |
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $231 |
| Kowa Pharmaceuticals America, Inc. | 13 | $220 |
| PFIZER INC. | 15 | $206 |
| Novo Nordisk Inc | 13 | $188 |
| GlaxoSmithKline, LLC. | 13 | $184 |
| Phathom Pharmaceuticals, Inc. | 10 | $161 |
Products named: REXULTI, AIRSUPRA, UBRELVY, Kerendia, JARDIANCE, ZORYVE, QULIPTA, VRAYLAR.
Industry payments across PA — which companies pay providers there.
